It has a high binding affinity and specificity to tumor-associated MUC1, decreased binding to circulating MUC1 from colon and pancreatic cancer patients, and no binding to peripheral blood mononuclear cells (PBMCs) [21]. Here, MUC1 is linked to neoplasm.